208 related articles for article (PubMed ID: 15592192)
1. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
Slart RH; Bax JJ; Sluiter WJ; van Veldhuisen DJ; Jager PL
J Nucl Cardiol; 2004; 11(6):689-96. PubMed ID: 15592192
[TBL] [Abstract][Full Text] [Related]
2. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
Raja S; Singh B; Rohit MK; Manohar K; Kashyap R; Bhattacharya A; Mittal BR
J Nucl Cardiol; 2012 Dec; 19(6):1176-81. PubMed ID: 22872319
[TBL] [Abstract][Full Text] [Related]
4. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
5. Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: MRI validation and comparison of the Emory Cardiac Tool Box with QGS and 4D-MSPECT.
Schaefer WM; Lipke CS; Standke D; Kühl HP; Nowak B; Kaiser HJ; Koch KC; Buell U
J Nucl Med; 2005 Aug; 46(8):1256-63. PubMed ID: 16085580
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
[TBL] [Abstract][Full Text] [Related]
7. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.
Matsunari I; Böning G; Ziegler SI; Nekolla SG; Stollfuss JC; Kosa I; Ficaro EP; Schwaiger M
J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
9. The value of attenuation correction by hybrid SPECT/CT imaging on infarct size quantification in male patients with previous inferior myocardial infarct.
Giubbini RM; Gabanelli S; Lucchini S; Merli G; Puta E; Rodella C; Motta F; Paghera B; Rossini P; Terzi A; Bertagna F
Nucl Med Commun; 2011 Nov; 32(11):1026-32. PubMed ID: 21897308
[TBL] [Abstract][Full Text] [Related]
10. Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging.
Lipke CS; Kühl HP; Nowak B; Kaiser HJ; Reinartz P; Koch KC; Buell U; Schaefer WM
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):482-90. PubMed ID: 14722679
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.
He W; Acampa W; Mainolfi C; Menna F; Sorrentino AR; Petretta M; Cuocolo A
J Nucl Cardiol; 2003; 10(6):599-606. PubMed ID: 14668771
[TBL] [Abstract][Full Text] [Related]
12. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
[TBL] [Abstract][Full Text] [Related]
13. Attenuation-corrected 99mTc-MIBI SPECT in overweight patients with chronic ischaemic dysfunction: a comparison to NH3 PET and implications for the diagnosis of myocardial viability.
Roelants V; Bernard X; Walrand S; Bol A; Coppens A; Jamart J; Melin J; Vanoverschelde JL
Nucl Med Commun; 2006 Oct; 27(10):815-21. PubMed ID: 16969265
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
[TBL] [Abstract][Full Text] [Related]
15. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
16. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
[TBL] [Abstract][Full Text] [Related]
18. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
[TBL] [Abstract][Full Text] [Related]
19. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial viability in dysfunctional myocardium by resting myocardial blood flow determined with oxygen 15 water PET.
Nowak B; Schaefer WM; Koch KC; Kaiser HJ; Block S; Knackstedt C; Zimny M; vom Dahl J; Buell U
J Nucl Cardiol; 2003; 10(1):34-45. PubMed ID: 12569329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
